Dva Renal Healthcare Inc
NPI #1548299373

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility located in East Orange, NJ

0
14-20 Prospect St
East Orange, NJ 07017-2238
(973) 672-2025

About

Dva Renal Healthcare Inc is a End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility (taxonomy code 261QE0700X) located in East Orange, New Jersey. Dva Renal Healthcare Inc's NPI Number is #1548299373 and has been listed in the NPI registry for 12 years. Dva Renal Healthcare Inc's practice location is listed as: 14-20 Prospect St East Orange, NJ 07017-2238 and can be reached via phone at (973) 672-2025.

Contact Information

NPI Number
1548299373
Website
Not provided

Address
14-20 Prospect St
East Orange, NJ 07017-2238

Specialties


Business Information

Sole-Proprietor?
Not Available
Is Sub-Organization?
No
Parent Organization Name
Not Applicable

About This listing

Last Updated
11/13/2012 5 years ago
Date Added
7/2/2006 11 years ago
Viewed On
6/23/2018 just now

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility Taxonomy Info

The taxonomy code for Dva Renal Healthcare Inc's main specialty, End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility, is 261QE0700X.

Click here to see more information about this taxonomy and find other providers that specialize in End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility

Ratings

Be the first to rate Dva Renal Healthcare Inc

Overall
Professionalism
Facilities
Availability
Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.


Health Care Providers Nearby











Success

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.